Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis.

Andersen, Henning; Mantegazza, Renato; Wang, Jing Jing; O'Brien, Fanny; Patra, Kaushik; Howard, James F

Andersen, Henning; Mantegazza, Renato; Wang, Jing Jing; O'Brien, Fanny; Patra, Kaushik; Howard, James F.

Afiliação

Andersen H; Department of Neurology, Aarhus University Hospital, Indgang J, Plan 5, Krydspunkt 504, Palle Juul-Jensens Boulevard, 8200, Aarhus N, Denmark. hennande@rm.dk.
Mantegazza R; Foundation of the Carlo Besta Neurological Institute, IRCCS, Milan, Italy.
Wang JJ; Formerly of Alexion Pharmaceuticals, Inc., New Haven, CT, USA.
O'Brien F; Alexion Pharmaceuticals, Inc., New Haven, CT, USA.
Patra K; Alexion Pharmaceuticals, Inc., New Haven, CT, USA.
Howard JF; Department of Neurology, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Qual Life Res ; 28(8): 2255, 2019 Aug.

Article em En | MEDLINE | ID: mdl-31115842

ABSTRACT

ABSTRACT

The article "Eculizumab improves fatigue in refractory generalized myasthenia gravis", written by "Henning Andersen, Renato Mantegazza, Jing Jing Wang, Fanny O'Brien, Kaushik Patra, James F. Howard Jr. and The REGAIN Study Group" was originally published electronically on the publisher's internet portal (currently SpringerLink) on 23 March 2019 without open access.

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Qual Life Res Assunto da revista: REABILITACAO / TERAPEUTICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google